Anti-prothrombin antibodies are associated with adverse pregnancy outcome

American Journal of Reproductive Immunology

Volumn 66, Issue 5, 2011, Pages 404-409

  Marozio, Luca ^a   Curti, Antonella ^a   Botta, Giovanni ^b   Canuto, Emilie M ^a   Salton, Loredana ^a   Tavella, Anna Maria ^a   Benedetto, Chiara ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Sant'Anna OIRM Hospital   (Italy)

Author keywords

Anti prothrombin antibodies; Antiphospholipid antibodies; Fetal death; Placental abruption; Pre eclampsia; Pregnancy outcome

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ANTIBODY; PROTEIN C ANTIBODY; PROTEIN S ANTIBODY; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS DEATH; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; SOLUTIO PLACENTAE; THROMBOPHILIA;

ABRUPTIO PLACENTAE; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; FEMALE; FETAL DEATH; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROTEIN C; PROTEIN S; PROTHROMBIN;

EID: 80054030630     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01031.x     Document Type: Article

References (28)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
2. Munoz-Rodriguez FJ, Reverter JC, Font J, Tassies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M: Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica 2000; 85:632-637.
3. Pasquier E, Amiral J, de Saint Martin L, Mottier D: A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism. Thromb Haemost 2001; 86:538-542.
4. Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R: Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 2005; 129:61-68.
5. von Landemberg P, Matthias T, Zaech J, Schultz M, Lorber M, Blank M, Shoenfeld Y: Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003; 49:51-56.
6. Sabatini L, Torricelli M, Scaccia V, Fineschi D, Pescaglini M, Gasparri L, Florio P, Petraglia F: Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions. Clin Chem 2007; 53:228-232.
7. Oosting JD, Derksen RHMW, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG: Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993; 81:2618-2625.
8. Song KS, Park YS, Kim HK: Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43:557-560.
9. Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y: Association between the prevalence of antibodies to β2 glycoprotein 1, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombocytopenic complications. Clin Chem 2001; 47:1008-1015.
10. Bertolaccini ML, Sanna G, Ralhan S, Gennari CC, Merrill JTT, Khamashta MA, Hughes GR: Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 2003; 90:636-641.
11. Borrel M, Tirado I, Mateo J, Oliver A, Santamaria A, Fontcuberta J: IgM anti-protein S antibodies as a risk factor for venous thrombosis. Haematologica 2008; 93:1115-1117.
12. Nojima J, Iwatani Y, Ichihara K, Tsuneoka H, Ishikawa T, Yanagihara M, Takano T, Hidaka Y: Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus. Thromb Res 2009; 124:127-131.
13. ACOG practice bulletin: Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77:67-75.
14. Mello G, Parretti E, Marozio L, Pizzi C, Lojacono A, Frusca T, Facchinetti F, Benedetto C: Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005; 46:1270-1274.
15. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study: Thrombophilia in pregnancy; a systematic review. Br J Haematol 2006; 132:171-196.
16. Lane DA, Philippou H, Huntington JA: Directing thrombin. Blood 2005; 106:2605-2612.
17. Amengual O, Atsumi T, Khamashta MA, Hughes GRV: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79:276-281.
18. Vega-Ostertag M, Liu X, Kwan-Ki H, Chen P, Pierangeli S: A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br J Haematol 2006; 135:214-219.
19. Kujovich JL: Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004; 191:412-424.
20. Meroni PL, Gerosa M, Raschi E, Scurati S, Grossi C, Borghi MO: Updating on the pathogenic mechanisms of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol 2008; 34:332-337.
21. Velayuthaprabhu S, Archunan G, Balakrishnan K: Placental thrombosis in experimental anticardiolipin antibodies-mediated intrauterine fetal death. Am J Reprod Immunol 2007; 57:270-276.
22. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594.
23. Mousa HA, Alfirevic Z: Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000; 15:1830-1833.
24. Vinnars MT, Wijnaendts LC, Westgren M, Boite AC, Papadogiannakis N, Nasiell J: Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension 2008; 51:1295-1299.
25. Di Simone N, Meroni PL, D'Asta M, Di Nicuolo F, D'Ippolito S, D'Alessio MC, Caruso A: Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies. Ann N Y Acad Sci 2007; 1108:505-514.
26. Sun WY, Witte DP, Degen JL, Colbert MC, Burkhart MC, Holmback K, Xiao Q, Bugge TH, Degen SJ: Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A 1998; 95:7597-7602.
27. Galli M: Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome? J Autoimmun 2000; 15:101-105.
28. Previtali S, Barbui T, Galli M: Anti-beta2-glycoprotein 1 and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case-control study. Thromb Haemost 2002; 88:729-732.